Dear ProLife Colleague, If you don’t know Ella One yet, you will soon! Ella-one is the newest emergency contraceptive agent, now commercially available in Europe. Ellaone is first cousin to Mifepristone (RU 486), the “medical abortion” drug that kills the baby by blocking placental function. Ellaone has the same action. The generic name is Ulipristal, and on June 17, the FDA will hold a hearing regarding accepting this drug as a new “emergency contraceptive” in the U.S.A. This drug is clearly an abortifacient agent. Ulipristal acetate prevents progesterone from occupying its receptor, thus the gene transcription normally turned on by progesterone is blocked, and the proteins necessary to begin and maintain pregnancy are not synthesized.” Remember that ACOG defines pregnancy as starting with implantation. Ulipristal blocks implantation. So, although it kills an embryonic human baby, by their definition it would not abort a pregnancy.. You sort that one out. Ulipristal acts as EC up to five days after fertilization. Implantation takes place 5 to 6 days after fertilization—at which point the progesterone blocker is in place, and implantation will be blocked or compromised. AAPLOG has given testimony to the FDA objecting to approving Ulipristal for the U.S. market. We urge you to read our testimony at: https://www.aaplog.org/?page_id=808 AAPLOG has concluded from publicly available information that ulipristal acetate is an abortifacient of the same type as mifepristone (“RU-486”) and that its approval as an emergency contraceptive raises serious health and ethical issues. Furthermore, ulipristal’s potential effects on women who used the drug off-label and upon ongoing pregnancies are essentially unexamined and untested. Ulipristal’s ability to destroy established pregnancies, as well as prevent implantation, makes it an embryocidal drug. If FDA were to approve NDA 22-274 without making clear to the public that ulipristal has a substantial abortifacient capability – that action would violate the public trust granted FDA by Congress. Ulipristal’s abortifacient mechanisms require that any approval occur with significant distribution restrictions and heightened notice to potential users. Now you have met Ella One. We predict you will be dealing with her fallout in the future. Look for the FDA decision after the June 17 hearing. ******************************************** When requested, we make service announcements on behalf of our members. See following: From: Dr. David Lang <deliverer32202@comcast.net> Subject: new opportunity I am and have been a member of AAPLOG for some time. I find myself seeking another opportunity. I live in the Kansas City Metro area but would relocate to the right practice. Aaplog note: if interested, communicate directly with Dr. Lang. (AAPLOG does not act as an intermediary)
Menu
Menu